Weight Loss

Metabolic·MeSH: Weight Loss

15 drugs in development·12 companies·5 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
lisdexamfetamine di	Amneal Pharmaceuticals, Inc. (AMRX)
syndros	Insys Therapeutics, Inc. (INSY)
ursodiol	Optec International, Inc. (GM)

Phase 3(3)

Drug	Company
revita dmr system	Fractyl Health Inc. (GUTS)
VK2735	Viking Therapeutics, Inc. (VKTX)
zeranovia	BIOADAPTIVES, INC. (BDPT)

Phase 1(2)

Drug	Company
ANPA-0073	Structure Therapeutics Inc. (GPCR)
el-22	PMGC Holdings Inc. (ELAB)

Preclinical(3)

Drug	Company
el-32	PMGC Holdings Inc. (ELAB)
rad011	Radius Health, Inc. (RDUS)
skny-1	MIRA PHARMACEUTICALS, INC. (MIRA)

Unknown(3)

Drug	Company
portfolio of weight loss medicines	Amneal Pharmaceuticals, Inc. (AMRX)
vitaslim	Polomar Health Services, Inc. (PMHS)
vitaslim plus	Polomar Health Services, Inc. (PMHS)

BLA Filed(1)

Drug	Company
apollo esg	Apollo Endosurgery, Inc. (APEN)

BioSniper tracks 15 drugs in development for Weight Loss across 12 companies.

There are 5 clinical trials targeting Weight Loss tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.